D A Hall

Summary

Affiliation: University of Colorado Health Sciences Center
Country: USA

Publications

  1. ncbi Clinical science training at the University of Colorado: a measurement of trainee satisfaction
    Deborah A Hall
    Department of Neurology, University of Colorado at Denver Health Sciences Center, Denver, CO, USA
    J Investig Med 55:181-6. 2007
  2. ncbi Paroxysmal nonkinesigenic dystonia and celiac disease
    Deborah A Hall
    Department of Neurology, University of Colorado, Health Sciences Center, Denver, CO 80262, USA
    Mov Disord 22:708-10. 2007
  3. ncbi Maternal risk factors for term neonatal seizures: population-based study in Colorado, 1989-2003
    Deborah A Hall
    Department of Neurology, University of Colorado at Denver and Health Sciences Center, 4200 East Ninth Avenue, Denver, CO 80262, USA
    J Child Neurol 21:795-8. 2006
  4. ncbi Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome
    Deborah A Hall
    Department of Neurology, University of Colorado Health Sciences Center at Denver, Denver, Colorado 80262, USA
    Mov Disord 21:1741-4. 2006
  5. ncbi Prevalence of FMR1 repeat expansions in movement disorders. A systematic review
    D A Hall
    Department of Neurology, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Neuroepidemiology 26:151-5. 2006
  6. pmc Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease
    Deborah A Hall
    Department of Neurology, University of Colorado at Denver and Health Sciences Center, Denver, CO, USA
    Parkinsonism Relat Disord 15:156-9. 2009
  7. ncbi PRNP H187R mutation associated with neuropsychiatric disorders in childhood and dementia
    D A Hall
    Department of Neurology, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Neurology 64:1304-6. 2005
  8. ncbi Initial diagnoses given to persons with the fragile X associated tremor/ataxia syndrome (FXTAS)
    D A Hall
    University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Neurology 65:299-301. 2005
  9. pmc FMR1 CGG repeat length predicts motor dysfunction in premutation carriers
    M A Leehey
    Department of Neurology, University of Colorado at Denver and Health Sciences Center, Denver, CO 80262, USA
    Neurology 70:1397-402. 2008
  10. doi Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome
    Jim Grigsby
    Department of Medicine, University of Colorado at Denver and Health Sciences Center, Aurora, CO 80045 5701, USA
    Neuropsychology 22:48-60. 2008

Research Grants

Detail Information

Publications20

  1. ncbi Clinical science training at the University of Colorado: a measurement of trainee satisfaction
    Deborah A Hall
    Department of Neurology, University of Colorado at Denver Health Sciences Center, Denver, CO, USA
    J Investig Med 55:181-6. 2007
    ..CLSC programs have expanded curricula that include teaching career development techniques, such as manuscript and grant writing, and helping young investigators establish successful mentor-mentee relationships...
  2. ncbi Paroxysmal nonkinesigenic dystonia and celiac disease
    Deborah A Hall
    Department of Neurology, University of Colorado, Health Sciences Center, Denver, CO 80262, USA
    Mov Disord 22:708-10. 2007
    ..We also review the literature regarding the genetic susceptibility to PNKD and celiac disease...
  3. ncbi Maternal risk factors for term neonatal seizures: population-based study in Colorado, 1989-2003
    Deborah A Hall
    Department of Neurology, University of Colorado at Denver and Health Sciences Center, 4200 East Ninth Avenue, Denver, CO 80262, USA
    J Child Neurol 21:795-8. 2006
    ..Maternal diabetic vasculopathy can also be a contributing factor...
  4. ncbi Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome
    Deborah A Hall
    Department of Neurology, University of Colorado Health Sciences Center at Denver, Denver, Colorado 80262, USA
    Mov Disord 21:1741-4. 2006
    ..This study suggests that patients with FXTAS can derive improvement from medication treatment for some of their symptoms...
  5. ncbi Prevalence of FMR1 repeat expansions in movement disorders. A systematic review
    D A Hall
    Department of Neurology, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Neuroepidemiology 26:151-5. 2006
    ..The heterogeneous design of the studies, inclusion criteria and mean age of subjects may have led to underestimation of FMR1 repeat expansion prevalence rates...
  6. pmc Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease
    Deborah A Hall
    Department of Neurology, University of Colorado at Denver and Health Sciences Center, Denver, CO, USA
    Parkinsonism Relat Disord 15:156-9. 2009
    ..Although screening all PD patients is likely to be low yield, genetic testing of FMR1 in individuals with PD and a family history of fragile X syndrome, autism or developmental delay, or other related FMR1 phenotypes is warranted...
  7. ncbi PRNP H187R mutation associated with neuropsychiatric disorders in childhood and dementia
    D A Hall
    Department of Neurology, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Neurology 64:1304-6. 2005
    ..Mutations in PRNP may cause neuropsychiatric disorders that predate dementia by many years...
  8. ncbi Initial diagnoses given to persons with the fragile X associated tremor/ataxia syndrome (FXTAS)
    D A Hall
    University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Neurology 65:299-301. 2005
    ..Data from this study and others were used to develop guidelines for FMR1 diagnostic testing for FXTAS...
  9. pmc FMR1 CGG repeat length predicts motor dysfunction in premutation carriers
    M A Leehey
    Department of Neurology, University of Colorado at Denver and Health Sciences Center, Denver, CO 80262, USA
    Neurology 70:1397-402. 2008
    ..This study determines whether CGG repeat length correlates with severity and type of motor dysfunction in premutation carriers...
  10. doi Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome
    Jim Grigsby
    Department of Medicine, University of Colorado at Denver and Health Sciences Center, Aurora, CO 80045 5701, USA
    Neuropsychology 22:48-60. 2008
    ..Longitudinal research currently underway will provide insight into the progression of the disorder...
  11. ncbi Progression of tremor and ataxia in male carriers of the FMR1 premutation
    Maureen A Leehey
    Department of Neurology, University of Colorado at Denver and Health Sciences Center, Denver, Colorado 80262, USA
    Mov Disord 22:203-6. 2007
    ..Preliminary data on life expectancy are variable, with a range from 5 to 25 years...
  12. ncbi Neuro-ophthalmic manifestations of neurodegenerative disease
    Victoria S Pelak
    Departments of Neurology and Ophthalmology, University of Colorado Health Sciences Center, 1635 North Ursula Street, Box F727, Aurora, CO 80010, USA
    Ophthalmol Clin North Am 17:311-20, v. 2004
    ....
  13. ncbi Adult-onset Alexander disease with progressive ataxia and palatal tremor
    Katherine L Howard
    Department of Neurology, University of Colorado at Denver Health Sciences Center, Denver, Colorado 80262, USA
    Mov Disord 23:118-22. 2008
    ..This is the oldest reported case with confirmation of a GFAP mutation. Onset was late in the sixth decade. Genetic analysis of the GFAP gene is recommended in cases of progressive ataxia and palatal tremor...
  14. ncbi Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population
    Sebastien Jacquemont
    MIND Institute, University of California Davis Medical Center, Sacramento, USA
    JAMA 291:460-9. 2004
    ..Additional documented symptoms include short-term memory loss, executive functional deficits, cognitive decline, parkinsonism, peripheral neuropathy, lower-limb proximal muscle weakness, and autonomic dysfunction...
  15. ncbi Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines
    Elizabeth Berry-Kravis
    Department of Pediatrics, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 22:2018-30, quiz 2140. 2007
    ..We also provide guidelines for the practitioner to assist with identifying appropriate patients for DNA testing for FXTAS, as well as recommendations for genetic counseling once a diagnosis of FXTAS is made...
  16. ncbi Neuropathic features in fragile X premutation carriers
    Elizabeth Berry-Kravis
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
    Am J Med Genet A 143:19-26. 2007
    ..These data suggest that neuropathic signs are associated with the fragile X premutation, presumably occurring through the same mechanism proposed for CNS disease, namely, toxicity from expanded-CGG-repeat FMR1 mRNA...
  17. ncbi Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation
    David Hessl
    Medical Investigation of Neurodevelopmental Disorders Institute, University of California Davis Medical Center, Sacramento, CA 95817, USA
    Am J Med Genet B Neuropsychiatr Genet 139:115-21. 2005
    ....
  18. pmc Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems
    Randi J Hagerman
    MIND Institute, University of California, Davis, School of Medicine, Sacramento, CA 95817, USA
    Clin Interv Aging 3:251-62. 2008
    ..The current review summarizes what is currently known regarding the symptomatic treatment, or potential for treatment, of FXTAS...
  19. ncbi Presentation modality influences behavioral measures of alerting, orienting, and executive control
    Katherine L Roberts
    Medical Research Council, Institute of Hearing Research, University Park, Nottingham, United Kingdom
    J Int Neuropsychol Soc 12:485-92. 2006
    ..The different spatial-orienting measures could reflect either separate orienting resources for each perceptual modality, or an interaction between a supramodal orienting resource and modality-specific perceptual processing...
  20. doi Persistent neurobehavioral signs and symptoms following West Nile fever
    Deborah A Hall
    J Neuropsychiatry Clin Neurosci 20:122-3. 2008

Research Grants2

  1. Prevalence of FMRI Expansions in Movement Disorders
    Deborah Hall; Fiscal Year: 2007
    ..These illnesses represent an important public health problem as they cause morbidity and mortality in our aging population. ..